Published in J Surg Res on February 01, 1993
Biliary acute pancreatitis:a review. World J Gastroenterol (2000) 0.92
Etiology and diagnosis of acute biliary pancreatitis. Nat Rev Gastroenterol Hepatol (2010) 0.89
Cholecystokinin antagonist L364,718 induces alterations in acinar cells that prevent improvement of acute pancreatitis induced by obstruction. Dig Dis Sci (2002) 0.75
Manometric heterogeneity in patients with idiopathic achalasia. Gastroenterology (2001) 2.11
Gangrenous cholecystitis: analysis of risk factors and experience with laparoscopic cholecystectomy. Surgery (1999) 1.79
Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology (1999) 1.71
Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology (2000) 1.47
First-trimester markers of aneuploidy in women positive for HIV. BJOG (2010) 1.41
Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery (2001) 1.28
Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs. Gastroenterology (1979) 1.22
Neurotensin stimulates growth of small intestine in rats. Am J Physiol (1988) 1.21
Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology (1988) 1.19
Central nervous system action of corticotropin-releasing factor to inhibit gastric emptying in rats. Am J Physiol (1987) 1.19
Laparoscopic inguinal hernia repair. A preliminary experience. Arch Surg (1993) 1.17
Cell site and time course of DNA synthesis in pancreas after caerulein and secretin. Am J Physiol (1983) 1.15
Elevated gastrin levels in patients with colon cancer or adenomatous polyps. Dig Dis Sci (1989) 1.15
Interaction of caerulein and secretin on pancreatic size and composition in rat. Am J Physiol (1978) 1.14
Acute diverticulitis. A complicated problem in the immunocompromised patient. Arch Surg (1991) 1.14
Decrease in serum cortisol during yoga exercise is correlated with alpha wave activation. Percept Mot Skills (2000) 1.13
Sequential dissociation of the exocrine pancreas into lobules, acini, and individual cells. Methods Cell Biol (1978) 1.13
A learning curve for laparoscopic splenectomy at an academic institution. J Surg Res (1999) 1.11
Inhibition of pancreatic secretion in man by cigarette smoking. Gut (1972) 1.11
Prevention of pneumonia in elderly stroke patients by systematic diagnosis and treatment of dysphagia: an evidence-based comprehensive analysis of the literature. Dysphagia (2001) 1.10
Effect of atropine and vagotomy on response of transplanted pancreas. Am J Physiol (1979) 1.10
Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci (1990) 1.06
Treatment of anastomotic leakage following low anterior colon resection. Arch Surg (1988) 1.06
One-stage resection and anastomosis in the management of colovesical fistula. Am J Surg (1987) 1.06
Bariatric surgery for morbid obesity. Obes Surg (2000) 1.02
Opioid drugs cause bile duct obstruction during hepatobiliary scans. Am J Surg (1984) 1.01
Esophagogastric junction pressure topography after fundoplication. Surgery (2000) 1.01
Impact of fundoplication on bolus transit across esophagogastric junction. Am J Physiol (1998) 1.01
Effects of nicotine on gastrointestinal secretions.. Gastroenterology (1971) 1.00
Distinct patterns of oesophageal shortening during primary peristalsis, secondary peristalsis and transient lower oesophageal sphincter relaxation. Neurogastroenterol Motil (2002) 0.99
Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats. Am J Physiol (1994) 0.99
Kartagener's syndrome with normal spermatozoa. JAMA (1987) 0.97
Effect of atropine on pancreatic response to HCl and secretin. Am J Physiol (1981) 0.97
Rates of morbidity and mortality after closure of loop and end colostomy. Surg Gynecol Obstet (1990) 0.96
CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. Regul Pept (1991) 0.96
Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am J Physiol Gastrointest Liver Physiol (2000) 0.96
Laparoscopic live donor nephrectomy--is it safe? Transplantation (2000) 0.95
Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg (1990) 0.95
Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2. Gastroenterology (1990) 0.95
Structure and receptor binding of PYY analogs. Peptides (2002) 0.93
Effect of gastric inhibitory polypeptide on pentagastrin-stimulated acid secretion in man. Dig Dis Sci (1980) 0.93
Symptomatic malignant melanoma of the gastrointestinal tract. Operative treatment and survival. Ann Surg (1984) 0.92
In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin. Peptides (1982) 0.92
Louse-borne relapsing fever in man. Arch Pathol (1974) 0.91
TGF-alpha is a potent mitogen for primary cultures of guinea pig gastric mucous epithelial cells. Am J Physiol (1993) 0.91
Additive interaction of pentagastrin and secretin on pancreatic growth in rats. Gastroenterology (1987) 0.90
Reduced tLESR elicitation in response to gastric distension in fundoplication patients. Am J Physiol Gastrointest Liver Physiol (2003) 0.90
Regulation of pancreatic secretion. Clin Gastroenterol (1984) 0.89
Effect of neurotensin on pancreatic and gastric secretion and growth in rats. Pancreas (1988) 0.89
External duodenal fistula. Causes, complications, and treatment. Arch Surg (1986) 0.89
Solution structure of monomeric peptide YY supports the functional significance of the PP-fold. Biochemistry (2000) 0.89
Cigarette smoking and duodenal-ulcer disease. N Engl J Med (1972) 0.88
Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33. Am J Physiol (1984) 0.88
Bile-pancreatic juice replacement not cholinergic- and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligation. Am J Surg (1996) 0.88
Effects of chronic administration of somatostatin on rat exocrine pancreas. Regul Pept (1982) 0.87
Effects of potent bombesin antagonist on exocrine pancreatic secretion in rats. Peptides (1991) 0.87
Effects of selective cholecystokinin antagonists L364,718 and L365,260 on food intake in rats. Peptides (1992) 0.87
Moxalactam. Evaluation of clinical bleeding in patients with abdominal infection. Arch Surg (1983) 0.86
Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic duct obstruction with and without bile duct obstruction. J Surg Res (1993) 0.86
Bile and pancreatic juice replacement ameliorates early ligation-induced acute pancreatitis in rats. Am J Surg (1995) 0.86
The evolution and long-term results of laparoscopic antireflux surgery for the treatment of gastroesophageal reflux disease. JSLS (2011) 0.86
Cystic neoplasms of the pancreas. A clinicopathologic study, including DNA flow cytometry. Arch Surg (1995) 0.85
Myocardial infarction and pulmonary embolism. Arch Pathol (1965) 0.85
Diagnosis and treatment of worker-related musculoskeletal disorders of the upper extremity. Evid Rep Technol Assess (Summ) (2002) 0.85
Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog. Gastroenterology (1979) 0.85
Trophic effects of pentagastrin on gastrointestinal tract in fed and fasted rats. Gastroenterology (1986) 0.84
Percutaneous cholecystostomy in the diagnosis and treatment of acute cholecystitis in the high-risk patient. Arch Surg (1989) 0.84
Primary gastrointestinal sarcomas: analysis of prognostic factors and results of surgical management. Surgery (2000) 0.84
The effects of thyrotropin releasing hormone (TRH) on the gastrointestinal tract. Life Sci (1979) 0.84
Effect of atropine on secretion from intact and transplanted pancreas in dog. Am J Physiol (1980) 0.83
Ligation-induced acute pancreatitis in rats and opossums: a comparative morphologic study of the early phase. J Surg Res (1994) 0.83
Exocrine pancreatic secretion in response to a new CCK-analog, CCK33 and caerulein in dogs. Regul Pept (1984) 0.82
Giant-cell tumor of the maxilla. Report of a case. Oral Surg Oral Med Oral Pathol (1978) 0.82
Endogenous opiates and gastric acid secretion. Gastroenterology (1980) 0.82
Does somatostatin analogue prevent experimental acute pancreatitis? Arch Surg (1990) 0.82
On the instability of secretin. Life Sci (1981) 0.82
[Cholecystokinin-pancreozymin synthesis. Synthesis of [28-threonine,31-norleucine]- and [28-threonine,31-leucine]cholecystokinin-pancreozymin-(25-33)-nonapeptide]. Hoppe Seylers Z Physiol Chem (1981) 0.81
Trophic effects of chronic bethanechol on pancreas, stomach, and duodenum in rats. Can J Physiol Pharmacol (1982) 0.81
Interaction between stimulants of exocrine pancreatic secretion in dogs. Am J Physiol (1984) 0.81
Complement component C5 deficiency reduces edema formation in murine ligation-induced acute pancreatitis. J Surg Res (1997) 0.81
Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs. Am J Physiol (1989) 0.81
Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa. Regul Pept (1991) 0.80
Muscarinic receptors and amylase secretion of rat pancreatic acini during cerulein-induced acute pancreatitis. Dig Dis Sci (1987) 0.80
Laparoscopic splenectomy. Surg Clin North Am (1996) 0.80
Hemangioma of the temporalis muscle: a case report and review of the literature. Ann Plast Surg (1979) 0.80
Cystic neoplasms of the pancreas. J Am Coll Surg (1994) 0.80
Results of gastric interposition for reconstruction of the pharyngoesophagus. Surgery (1999) 0.80
Dose-related involvement of CCK in bombesin-induced pancreatic growth. Regul Pept (1992) 0.80
Ligation-induced acute pancreatitis increases pancreatic circulating trypsinogen activation peptides. J Surg Res (1996) 0.80
Initial experience of laparoscopic cholecystectomy in a district hospital. Ulster Med J (1992) 0.80
Obstructive jaundice caused by hepatocellular carcinoma. J Surg Oncol (1984) 0.79